CDR2 inhibits c-Myc-dependent transcription in tumour cell lines; CDR2 has a similar transcriptional regulatory role against NFkB, the transcription factor involved in neuronal development and synaptic plasticity, and against MRGX, the transcriptional regulator involved in cell growth, DNA repair, and apoptosis [3]. The gene discussed is MYC; the disease is neoplasm.